Items where authors include "Jankovic, D."

Article

Woods, B. orcid.org/0000-0002-7669-9415, Kearns, B., Schmitt, L. et al. (15 more authors) (2025) Assessing the value of new antimicrobials: evaluations of cefiderocol and ceftazidime-avibactam to inform delinked payments by the NHS in England. Applied Health Economics and Health Policy, 23 (1). pp. 5-17. ISSN 1175-5652

Harnan, S. orcid.org/0000-0002-9318-9206, Kearns, B. orcid.org/0000-0001-7730-668X, Scope, A. orcid.org/0000-0003-1604-1758 et al. (11 more authors) (2024) Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model. Health Technology Assessment, 28 (73). ISSN 1366-5278

Woods, B. orcid.org/0000-0002-7669-9415, Schmitt, L. orcid.org/0000-0003-1052-488X, Jankovic, D. orcid.org/0000-0002-9311-1409 et al. (10 more authors) (2024) Cefiderocol for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model. Health Technology Assessment, 28 (28). pp. 1-238. ISSN 1366-5278

Squires, H. orcid.org/0000-0002-2776-4014, Jankovic, D. and Bojke, L. (2023) Reflecting parameter uncertainty in addition to variability in constrained healthcare resource discrete event simulations: worth going the extra mile or a road to nowhere? Value in Health, 26 (12). pp. 1738-1743. ISSN 1098-3015

Kullberg, M.C., Jankovic, D., Feng, C.G. et al. (8 more authors) (2006) IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis. Journal of Experimental Medicine, 203 (11). pp. 2485-2494. ISSN 0022-1007

Kullberg, M.C., Andersen, J.F., Gorelick, P.L. et al. (6 more authors) (2003) Induction of colitis by a CD4+ T-cell clone specific for a bacterial epitope. Proceedings of the National Academy of Sciences of the United States of America, 100 (26). pp. 15830-15835. ISSN 0027-8424

Kullberg, M.C., Jankovic, D., Gorelick, P.L. et al. (4 more authors) (2002) Bacteria-triggered CD4+ T regulatory cells suppress Helicobacter hepaticus-induced colitis. Journal of Experimental Medicine, 196 (4). pp. 505-515. ISSN 0022-1007